So they authorized more shares. Question is do they want to be a fraction of a penny company or scale the wall back to where they were or even higher? As it stands the investor note holders they have must be in short and taking bid. That makes the climb back tougher. Some of the moves they made already surprised me because this stock could have held its own had they staved off the collapse from being ill prepared in the initial FDA inspection. A little revenue reported. The next couple months will show if this is going to be around a while or one of those forever lingering .0007 stocks. The company seems very quiet about is next moves.